Want to see HCTI full AI Analyst Report?
Top Page
Healthcare Triangle
(NASDAQ:HCTI)
Select Model
Select Model
Rating:41Neutral
Price Target:
$0.67
▼(-20.36% Downside)
Action:Reiterated
Date:10/03/26
HCTI scores low primarily due to persistent, severe losses and heavy negative free cash flow, which dominate the financial profile despite rebounding revenue and improved equity. Technical signals are also weak (price below major moving averages with negative MACD), and corporate events add meaningful downside risk via the Nasdaq delisting determination. Valuation provides limited support because losses (negative P/E) reduce comparability and no dividend yield is available.
Positive Factors
Revenue Rebound
The return to strong top-line growth indicates renewed customer demand for Healthcare Triangle’s services after a volatile period. If sustained, higher revenue can improve delivery scale, support investments in cloud and data capabilities, and provide a foundation for future operating leverage.
Negative Factors
Severe Unprofitability
Deep operating and net losses show that revenue growth is not currently translating into economically sustainable earnings. The lower gross margin also suggests limited cost absorption, so continued expansion may require additional funding unless delivery efficiency and the cost structure improve materially.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Rebound
The return to strong top-line growth indicates renewed customer demand for Healthcare Triangle’s services after a volatile period. If sustained, higher revenue can improve delivery scale, support investments in cloud and data capabilities, and provide a foundation for future operating leverage.
Read all positive factors
Healthcare Triangle (HCTI) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$10.51M
Dividend YieldN/A
Average Volume (3M)3.00M
Price to Earnings (P/E)―
Beta (1Y)0.66
Revenue Growth116.40%
EPS Growth99.31%
CountryUS
Employees40
SectorHealthcare
Sector Strength45
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)-65.57
Shares Outstanding14,974,322
10 Day Avg. Volume8,498,034
30 Day Avg. Volume3,001,716
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.24
Price to Sales (P/S)0.17
P/FCF Ratio-0.14
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-10.96
Revenue Forecast (FY)$42.48M
Healthcare Triangle Business Overview & Revenue Model
Company Description
Healthcare Triangle, Inc. (HCTI) is a technology firm dedicated to the healthcare sector, specializing in crafting innovative solutions across cloud services, data science, and professional and managed IT support. The company provides a comprehens...
How the Company Makes Money
HCTI primarily makes money by delivering services and solutions to healthcare and life-sciences customers under commercial agreements. Key revenue streams include: (1) Professional services/implementation revenue from project-based work such as cl...
Healthcare Triangle Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
43
Neutral
Cash Flow
12
Very Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 25.68M | 13.89M | 11.70M | 33.20M | 45.89M | 35.27M |
| Gross Profit | 4.72M | 1.89M | 2.89M | 6.78M | 11.29M | 10.52M |
| EBITDA | -14.66M | -8.20M | -3.85M | -6.12M | -10.70M | -3.94M |
| Net Income | -17.02M | -9.48M | -5.97M | -8.69M | -14.36M | -5.95M |
Balance Sheet | ||||||
| Total Assets | 73.64M | 22.74M | 1.96M | 6.86M | 13.26M | 24.61M |
| Cash, Cash Equivalents and Short-Term Investments | 1.91M | 7.63M | 20.00K | 1.23M | 1.34M | 1.77M |
| Total Debt | 13.00M | 10.74M | 2.65M | 3.88M | 2.69M | 3.45M |
| Total Liabilities | 24.63M | 12.79M | 7.08M | 8.25M | 7.22M | 8.48M |
| Stockholders Equity | 49.10M | 9.98M | -5.11M | -1.39M | 6.04M | 16.14M |
Cash Flow | ||||||
| Free Cash Flow | -23.66M | -16.52M | -1.08M | -2.16M | -6.49M | -10.24M |
| Operating Cash Flow | -16.11M | -16.52M | -1.08M | -2.15M | -5.35M | -7.11M |
| Investing Cash Flow | -10.39M | -1.75M | 0.00 | -12.00K | -1.13M | -7.63M |
| Financing Cash Flow | 25.15M | 25.88M | -133.00K | 2.06M | 6.06M | 15.11M |
Healthcare Triangle Technical Analysis
Negative
0.84
Price Trends
0.97
Negative
1.55
Negative
9.38
Negative
Market Momentum
-0.07
Negative
42.02
Neutral
2.53
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HCTI, the sentiment is Negative. The current price of 0.84 is above the 20-day moving average (MA) of 0.75, below the 50-day MA of 0.97, and below the 200-day MA of 9.38, indicating a bearish trend. The MACD of -0.07 indicates Negative momentum. The RSI at 42.02 is Neutral, neither overbought nor oversold. The STOCH value of 2.53 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HCTI.
Healthcare Triangle Risk Analysis
Healthcare Triangle disclosed 43 risk factors in its most recent earnings report. Healthcare Triangle reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Healthcare Triangle Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | $4.86B | 34.46 | 3.59% | ― | 19.23% | 44.44% | |
66 Neutral | $643.05M | 58.48 | 3.01% | ― | 12.93% | ― | |
63 Neutral | $86.69M | 28.94 | 16.56% | ― | 15.07% | ― | |
53 Neutral | $127.94M | -0.48 | -129.70% | ― | -7.54% | -143.41% | |
52 Neutral | $383.27M | -0.77 | -99.16% | ― | -4.50% | -184.71% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
41 Neutral | $10.51M | -0.01 | -56.46% | ― | 116.40% | 99.31% |
* Healthcare Sector Average
HCTI
Healthcare Triangle
0.73
-159.48
-99.55%
CCLD
CareCloud
2.02
-1.37
-40.41%
EVH
Evolent Health
3.46
-4.77
-57.96%
PHR
Phreesia
10.07
-13.20
-56.73%
HCAT
Health Catalyst
1.75
-1.21
-40.88%
WAY
Waystar Holding Corp.
24.81
-13.83
-35.79%
Healthcare Triangle Corporate Events
Delistings and Listing ChangesRegulatory Filings and ComplianceStock Split
Healthcare Triangle Faces Nasdaq Delisting After Bid-Price Breach
Negative
Oct 2, 2026
On October 1, 2026, Healthcare Triangle, Inc. received a notice from Nasdaq’s Listing Qualifications Department stating that the company is not in compliance with the minimum $1.00 bid price requirement for continued listing on the Nasdaq Ca...
Business Operations and StrategyPrivate Placements and Financing
Healthcare Triangle Amends Equity Funding Agreement Terms
Neutral
Sep 25, 2026
On September 22, 2026, Healthcare Triangle amended its June 12, 2026 equity purchase agreement with Hudson Global Ventures, adjusting key financing terms that govern how the company can raise capital through equity puts to the investor. The change...
Business Operations and StrategyDelistings and Listing ChangesRegulatory Filings and Compliance
Healthcare Triangle advances Teyame AI spin-off plans
Positive
Sep 8, 2026
On September 2, 2026, Healthcare Triangle entered into a Separation and Distribution Agreement and a Transition Services Agreement with its subsidiary Teyame AI Holdings to execute a planned spin-off and public listing of Teyame. HCTI will distrib...
Business Operations and StrategyDelistings and Listing ChangesM&A TransactionsRegulatory Filings and ComplianceShareholder Meetings
Healthcare Triangle Expands Share Base, Strengthens Nasdaq Standing
Positive
Jul 29, 2026
On July 24, 2026, Healthcare Triangle completed the issuance of 12,546,540 common shares tied to two previously approved legacy MA transactions: the acquisition involving Teyame AI LLC and a share exchange agreement with SecureKloud Technologies L...
Business Operations and StrategyPrivate Placements and FinancingShareholder Meetings
Healthcare Triangle Shareholders Approve Key Governance Measures
Positive
Jul 20, 2026
At its virtual annual meeting on July 17, 2026, Healthcare Triangle shareholders backed all board nominees for one-year terms and ratified SRCO Professional Corporation as the independent auditor for the 2026 fiscal year. Investors representing ab...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.